HR 3116 · 113th Congress 2013–2015, ended

MODDERN Cures Act of 2013

Latest action · Jan 9, 2014 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 17, 2013
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2013 or MODDERN Cures Act of 2013 - Requires the Secretary of Health and Human Services (HHS) to: (1) establish the Advanced Diagnostics Education Council to recommend standard terms and definitions related to innovative diagnostics for use by patients, physicians, health care providers, payers, and policy makers; and (2) publish a guide regarding such terms and definitions.

Sets forth additional factors for the Secretary to consider in determining the payment amount for new clinical diagnostic laboratory tests under gap filling procedures which are used when no comparable existing test is available.

Extends the exclusivity period for a medicine if the diagnostic test related to such drug has been determined by the Secretary to have been developed by, or with the participation of, the manufacturer or sponsor of the medicine, and use of the diagnostic tests provides for or improves: (1) the identification of a patient population for the medicine; or (2) the determination of the most appropriate treatment option for a patient population with the medicine.

Establishes a dormant therapy designation for medicine that addresses unmet medical needs. Gives such medicine 15 years of data exclusivity under which no drug can be approved by relying on the approval or licensure of the dormant therapy.

Directs the Secretary to arrange with the Institute of Medicine (or, if it declines, another appropriate entity) to study intellectual property laws and their impact on therapy and diagnostic development in order to formulate recommendations on how to facilitate the clinical evaluation and development of therapies currently available on the market for new potential indications.

Cosponsors 95

Members who signed on, in the order they did. Signatures ran from Sep 17, 2013 to Jan 2, 2015; 15 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-PAAllyson Y. SchwartzOriginalSep 17, 2013
D-NMBen Ray LujánOriginalSep 17, 2013
R-MOBilly LongOriginalSep 17, 2013
R-KYBrett GuthrieOriginalSep 17, 2013
D-NYCharles B. RangelOriginalSep 17, 2013
D-IADavid LoebsackOriginalSep 17, 2013
R-MNErik PaulsenOriginalSep 17, 2013
R-ORGreg WaldenOriginalSep 17, 2013
R-NJJon RunyanOriginalSep 17, 2013
D-MNKeith EllisonOriginalSep 17, 2013
R-TXMichael T. McCaulOriginalSep 17, 2013
R-OHPatrick J. TiberiOriginalSep 17, 2013
R-ILPeter J. RoskamOriginalSep 17, 2013
R-NYPeter T. KingOriginalSep 17, 2013
R-NCWalter B. JonesOriginalSep 17, 2013
R-FLAnder CrenshawSep 18, 2013
R-INLarry BucshonSep 18, 2013
R-MNMichele BachmannSep 18, 2013
D-FLCorrine BrownSep 30, 2013
R-IATom LathamSep 30, 2013
D-FLTheodore E. DeutchOct 8, 2013
D-ILBradley Scott SchneiderOct 30, 2013
R-MITim WalbergOct 30, 2013
R-INTodd YoungNov 13, 2013
R-TXPete SessionsJan 29, 2014
D-WIGwen MooreFeb 3, 2014
D-RIJames R. LangevinFeb 3, 2014
D-IABruce L. BraleyFeb 5, 2014
D-CAMark TakanoFeb 10, 2014
D-INAndré CarsonFeb 25, 2014
D-RIDavid N. CicillineFeb 26, 2014
D-CAJulia BrownleyFeb 27, 2014
R-PAJim GerlachFeb 28, 2014
D-MNBetty McCollumMar 4, 2014
R-VARobert J. WittmanMar 6, 2014
R-CADana RohrabacherMar 12, 2014
D-CAJared HuffmanMar 12, 2014
R-TNJohn J. Duncan, Jr.Mar 25, 2014
R-NCRenee L. EllmersMar 25, 2014
R-FLGus M. BilirakisMar 26, 2014
R-WIReid J. RibbleApr 29, 2014
D-NYSteve IsraelMay 7, 2014
D-CAAnna G. EshooMay 9, 2014
R-MOBlaine LuetkemeyerMay 9, 2014
D-NHCarol Shea-PorterMay 9, 2014
D-NYDaniel B. MaffeiMay 9, 2014
R-CADevin NunesMay 20, 2014
D-VAJames P. MoranMay 20, 2014
D-GASanford D. Bishop, Jr.May 20, 2014
D-AZEd PastorMay 21, 2014
D-NCG. K. ButterfieldMay 22, 2014
R-AKDon YoungMay 28, 2014
D-OHJoyce BeattyMay 28, 2014
D-NJBill Pascrell, Jr.May 30, 2014
D-NYPaul TonkoJun 9, 2014
D-MNCollin C. PetersonJun 17, 2014
D-NJDonald M. Payne, Jr.Jun 23, 2014
R-NYMichael G. GrimmJun 23, 2014
R-PAGlenn ThompsonJun 26, 2014
D-CABarbara LeeJul 9, 2014
R-PAMichael G. FitzpatrickJul 9, 2014
D-PAMatt CartwrightJul 10, 2014
D-DCEleanor Holmes NortonJul 15, 2014
D-CAMike ThompsonJul 17, 2014
R-FLIleana Ros-LehtinenJul 31, 2014
D-CAScott H. PetersJul 31, 2014
R-MOAnn WagnerSep 9, 2014
R-NCGeorge HoldingSep 9, 2014
D-UTJim MathesonSep 9, 2014
D-FLJoe GarciaSep 9, 2014
R-NELee TerrySep 9, 2014
R-ILRandy HultgrenSep 9, 2014
D-MNTimothy J. WalzSep 9, 2014
R-FLVern BuchananSep 9, 2014
D-OHTim RyanSep 16, 2014
R-INLuke MesserSep 18, 2014
D-MAJoseph P. Kennedy IIINov 12, 2014
R-MNJohn KlineNov 13, 2014
R-AZDavid SchweikertNov 18, 2014
D-FLAlcee L. HastingsNov 20, 2014
R-SCJoe WilsonDec 1, 2014
R-INMarlin A. StutzmanDec 2, 2014
R-MSSteven M. PalazzoDec 2, 2014
R-INJackie WalorskiDec 3, 2014
D-MAMichael E. CapuanoDec 3, 2014
R-NJRodney P. FrelinghuysenDec 3, 2014
D-MARichard E. NealDec 8, 2014
R-TNDavid P. RoeDec 10, 2014
R-NCHoward CobleDec 10, 2014
D-MAKatherine M. ClarkDec 10, 2014
R-INSusan W. BrooksDec 10, 2014
D-MDC. A. Dutch RuppersbergerDec 11, 2014
D-MOWm. Lacy ClayDec 11, 2014
R-MIDan BenishekDec 12, 2014
D-MANiki TsongasJan 2, 2015

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 17, 2013
Health Subcommittee
Referred Sep 20, 2013
HouseWays and Means Committee
Referred Sep 17, 2013
HouseJudiciary Committee
Referred Sep 17, 2013
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
Referred Jan 9, 2014

Actions 4

Everything that happened, newest first.

  1. Jan 9, 2014Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
  2. Sep 20, 2013Referred to the Subcommittee on Health.
  3. Sep 17, 2013Introduced in House
  4. Sep 17, 2013Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H4480Glenn Thompson R-PAMay 20, 2014

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3

The sponsor’s statement, as printed in the page H5589.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 113-14CUTTING DHS DUPLICATION AND WASTEFUL SPENDING: IMPLEMENTING PRIVATE-SECTOR BEST PRACTICES AND WATCHDOG REC- OMMENDATIONS80 pagesHomeland Security CommitteeApr 26, 2013

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 2085Diagnostic Innovation Testing and Knowledge Advancement Act of 2013Related billJun 3, 2013
HR 3091MODDERN Cures Act of 2013Related billOct 15, 2013

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To promote the development of meaningful treatments for patients.
Short Titles as Introduced
MODDERN Cures Act of 2013
Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2013

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 17, 2013Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.